TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Uterine arteriovenous malformations – clinical implications

Key Statistics

  • <100 — Cases reported in literature
  • 0.6–4.5% — Incidence on pelvic USS for AVM
  • ≥0.83 m/s — PSV threshold → likely embolisation

Don't-miss facts

  1. Suspect uterine AVM in reproductive-age women with unexplained heavy/episodic vaginal bleeding, negative pregnancy test, after delivery/miscarriage/uterine procedure (median 11 months post-intervention)

  2. Never perform curettage if AVM suspected – risk of torrential haemorrhage

  3. Gold standard investigation: digital subtraction pelvic angiography; spectral Doppler recommended in all women with recurrent heavy bleeding

  4. PSV ≥0.83 m/s → likely needs embolisation; PSV <0.39 m/s → embolisation not required

  5. Lesion size does not correlate with need for embolisation; haemodynamic status is the main determinant of management

  6. UAE is first-line, fertility-sparing, minimally invasive; long-term success 79–92%; hysterectomy reserved for failed embolisation or no fertility wish

  7. Post-treatment: menstrual cycle and fertility return to normal in the vast majority; no reported uterine rupture in subsequent labours

  8. EMV (postpartum, resolves by 6 weeks) and subinvolution of the placental bed (delayed PPH, USS negative for RPOC) are key differentials, not true AVM

Treatment ladder

Medical: COCP / danazol / GnRH agonist / progestogens

Uterine artery embolisation (first line if bleeding needs transfusion/recurrent)

Hysterectomy: reserved for failed embolisation / no fertility wish

Abbreviation Key

  • AVM — arteriovenous malformation
  • GTD — gestational trophoblastic disease
  • EMV — enhanced myometrial vascularity
  • UAE — uterine artery embolisation
  • PSV — peak systolic velocity
  • PVA — polyvinyl alcohol
  • RI — resistance index
  • n-BCA — n-butyl cyanoacrylate
  • MRI — magnetic resonance imaging
  • COCP — combined oral contraceptive pill
  • RPOC — retained products of conception
  • GnRH — gonadotrophin-releasing hormone

Source: Katimada Annaiah T, Kodakkattil Sreenivasan S. Uterine arteriovenous malformations: clinical implications. The Obstetrician & Gynaecologist 2015;17:243–250. doi:10.1111/tog.12218

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free